A detailed history of Citigroup Inc transactions in Intercure Ltd. stock. As of the latest transaction made, Citigroup Inc holds 521 shares of INCR stock, worth $609. This represents 0.0% of its overall portfolio holdings.

Number of Shares
521
Holding current value
$609
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.71 - $2.62 $890 - $1,365
521 New
521 $1,000
Q3 2022

Nov 10, 2022

BUY
$4.23 - $6.54 $152 - $235
36 New
36 $0
Q2 2022

Aug 10, 2022

SELL
$5.62 - $7.5 $28,796 - $38,430
-5,124 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$5.7 - $8.2 $28,904 - $41,582
5,071 Added 9567.92%
5,124 $36,000
Q4 2021

Feb 10, 2022

BUY
$6.48 - $8.66 $343 - $458
53 New
53 $0

Others Institutions Holding INCR

About Intercure Ltd.


  • Ticker INCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,133,900
  • Market Cap $52.8M
  • Description
  • InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...
More about INCR
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.